These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22738256)

  • 1. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.
    Zhou Q; Wu S; Jiang J; Tian J; Chen J; Yu X; Chen P; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Xie DI; Liu J; Xu X; Liang M; Hou F
    Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
    Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
    Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does dialysis modality influence the oxidative stress of uremic patients?
    Capusa C; Stoian I; Rus E; Lixandru D; Barbulescu C; Mircescu G
    Kidney Blood Press Res; 2012; 35(4):220-5. PubMed ID: 22223182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
    González-Michaca L; Mercado A; Gamba G
    Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
    J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis type may predict carotid intima media thickness and plaque presence in end-stage renal disease patients.
    Mutluay R; Degertekin CK; Poyraz F; Yılmaz MI; Yücel C; Turfan M; Tavil Y; Derici Ü; Arınsoy T; Sindel S
    Adv Ther; 2012 Apr; 29(4):370-82. PubMed ID: 22467434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
    Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
    Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vitamin C deficiency and dialysis modalities.
    Zhang K; Dong J; Cheng X; Bai W; Guo W; Wu L; Zuo L
    Nephrology (Carlton); 2012 Jul; 17(5):452-7. PubMed ID: 22404236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.